Semaglutide
GLP-1 medication
Established GLP-1 care with a substantial clinical evidence base.
A once-weekly GLP-1 option that can support appetite regulation and long-term weight management for eligible patients.
Discuss this optionWhat is Semaglutide?
Semaglutide is the active ingredient in several prescription medicines. In weight care, it works with the body’s appetite signals and may help eligible patients eat less while building sustainable nutrition and activity habits.
Wegovy is the semaglutide product approved for chronic weight management in certain eligible patients. Other semaglutide products have different approved uses, and compounded products are not FDA approved. Important warnings and contraindications apply, including a boxed warning related to thyroid C-cell tumors.
Supports the body’s appetite signals
Semaglutide acts on GLP-1 receptors. GLP-1 is a hormone involved in appetite, food intake, and blood-sugar regulation. By mimicking this signal, treatment can help eligible patients feel satisfied with less food and follow a sustainable care plan.
Why patients ask about it
- A widely recognized option with extensive weight-management research
- Supports reduced appetite and calorie intake
- Designed for long-term weight management when prescribed appropriately
- Some branded semaglutide products have additional cardiovascular indications for specific eligible adults*
What thoughtful care looks like.
The right treatment is not selected from a menu alone. It follows an individual review and a plan for monitoring.
Your health history, current medicines, and goals are reviewed first.
A provider chooses the product, starting plan, and follow-up schedule.
Treatment is adjusted gradually when clinically appropriate.
Progress and side effects are discussed during follow-up care.
Common effects to discuss.
Gastrointestinal effects are common with this medication class, especially while the body adjusts. A provider can explain what is expected, what may help, and when to seek care.
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal discomfort
This is not a complete list of side effects, warnings, interactions, or contraindications.
What patients often want to know.
Is semaglutide a short-term program?
Weight management is usually approached as ongoing care. Your provider will discuss the expected duration, follow-up, and what a sustainable plan means for you.
How is a plan selected?
A provider considers your health history, current medicines, previous weight-care experience, goals, and ability to tolerate treatment before making a recommendation.
Will I automatically receive a prescription?
No. Completing an intake begins an evaluation. A licensed provider decides whether treatment is medically appropriate after reviewing your individual information.
Bring your questions. We’ll start with your health.
A completed intake helps a licensed provider understand whether this option may belong in your care plan.
Begin your intake